284 related articles for article (PubMed ID: 25448577)
1. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
2. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
3. Increased drug load and polymer compatibility of bilayered orodispersible films.
Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
[TBL] [Abstract][Full Text] [Related]
4. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
5. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
6. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
[TBL] [Abstract][Full Text] [Related]
7. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
8. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
9. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
11. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
Foo WC; Khong YM; Gokhale R; Chan SY
Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
[TBL] [Abstract][Full Text] [Related]
12. SOFTs - Structured orodispersible film templates.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
[TBL] [Abstract][Full Text] [Related]
13. Orodispersible films and tablets with prednisolone microparticles.
Brniak W; Maślak E; Jachowicz R
Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
[TBL] [Abstract][Full Text] [Related]
14. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Kokott M; Lura A; Breitkreutz J; Wiedey R
Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
[TBL] [Abstract][Full Text] [Related]
16. Application of miniaturized near-infrared spectroscopy for quality control of extemporaneous orodispersible films.
Foo WC; Widjaja E; Khong YM; Gokhale R; Chan SY
J Pharm Biomed Anal; 2018 Feb; 150():191-198. PubMed ID: 29247960
[TBL] [Abstract][Full Text] [Related]
17. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
El-Bary AA; Al Sharabi I; Haza'a BS
Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
[TBL] [Abstract][Full Text] [Related]
18. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
Woertz C; Kleinebudde P
Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
[TBL] [Abstract][Full Text] [Related]
19. Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability.
Woertz C; Kleinebudde P
Int J Pharm; 2015 Sep; 493(1-2):134-45. PubMed ID: 26216415
[TBL] [Abstract][Full Text] [Related]
20. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based Orodispersible Films Loaded with Entecavir: Formulation and In vitro Characterization.
Wei T; Zhou BY; Wu XH; Liu XA; Huo MW; Huang XX; Shi LZ; Shi LL; Cao QR
Curr Drug Deliv; 2023 Oct; ():. PubMed ID: 37929732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]